Green Leaf Innovations, Inc. Achieves Over 2,200% Revenue Growth Year[...]
New Findings Show Moleculin’s Annamycin Overcomes Resistance to[...]
Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian[...]
11/18/2024 | Press release | Distributed by Public on 11/18/2024 07:21
Please select the service you want to use:
Smartlinks | Moleculin Biotech Inc. | News | Health | Company News | Top Company News | Shareholder Meeting | Investment Funds | Pharmaceuticals | Lifestyle and Leisure | Leisure | Securities Issuers | Pharmaceutical Companies | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Berlin Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact